iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Intellectus Partners LLC

Intellectus Partners LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,016 shares of the financial services provider’s stock after selling 483 shares during the quarter. Intellectus Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,583,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in IBB. International Assets Investment Management LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $76,425,000. Itau Unibanco Holding S.A. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $48,242,000. Miracle Mile Advisors LLC raised its position in shares of iShares Biotechnology ETF by 0.4% during the 3rd quarter. Miracle Mile Advisors LLC now owns 325,333 shares of the financial services provider’s stock worth $39,785,000 after purchasing an additional 1,399 shares during the period. Bank Julius Baer & Co. Ltd Zurich raised its position in shares of iShares Biotechnology ETF by 3.7% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 293,097 shares of the financial services provider’s stock worth $35,843,000 after purchasing an additional 10,542 shares during the period. Finally, Raymond James Financial Services Advisors Inc. raised its position in shares of iShares Biotechnology ETF by 8.9% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 153,692 shares of the financial services provider’s stock worth $20,879,000 after purchasing an additional 12,611 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.7 %

IBB traded up $0.82 during trading hours on Friday, hitting $126.49. The company’s stock had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. The company has a 50-day simple moving average of $134.27 and a 200 day simple moving average of $129.74. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.